Current Concepts in Antifungal Pharmacology

Slides:



Advertisements
Similar presentations
Before and after slides: -Less text and bullets-more pictures -Make pictures the center and not the text -Use nice large high-definition pictures -No more.
Advertisements

Quick Anti-fungals By Sarah E.. Anti-fungals Name the 6 categories of anti-fungals 1.Polyenes 2.-azoles 3.Synthetic allylamines 4.Anti-metabolites 5.Echinocandins.
Selection of an optimal antifungal for treatment of invasive aspergillosis: susceptibility/resistance, adverse reactions, drug interactions John Bennett,
Diversity of Fungi and Fungal Infections
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
Clinical Pharmacology, Uses, and Adverse Reactions of Iodinated Contrast Agents: A Primer for the Non-radiologist Jeffrey J. Pasternak, MD, Eric E. Williamson,
My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:
Brielle Haas RISE Spring 2015 Dr. Gullo
Sites of action of antifungal drugs
Diversity of Fungi and Fungal Infections
Diverticulosis and Diverticulitis
80-Year-Old Man With Massive Leg Swelling
Anti-fungal agents Problem: Fungi are eukaryotes
Vitamin D Insufficiency
J. Eric Ahlskog, PhD, MD  Mayo Clinic Proceedings 
Diverticulosis and Diverticulitis
Regenerative Medicine in Diabetes
Y. Hicheri, G. Cook, C. Cordonnier  Clinical Microbiology and Infection 
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations.
William L. Lanier, MD  Mayo Clinic Proceedings 
The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research  Wayne.
Urine Drug Screening: Practical Guide for Clinicians
Management of Adult Onset Seizures
Larry M. Baddour, M.D.  Mayo Clinic Proceedings 
Mechanisms of Drug-Induced Allergy
Corticosteroids in the Treatment of Alcohol-Induced Rhabdomyolysis
Y. Hicheri, G. Cook, C. Cordonnier  Clinical Microbiology and Infection 
Acquired Long QT Syndrome and Monomorphic Ventricular Tachycardia After Alternative Treatment With Cesium Chloride for Brain Cancer  Anuj K. Dalal, MD,
Untitled by Martin Blank
Palliative Care and Hospice Programs
Topical Analgesics in the Management of Acute and Chronic Pain
Volume 92, Issue 5, Pages (March 1998)
The Need for Randomized Trials to Prove the Safety and Efficacy of Parachutes, Bulletproof Vests, and Percutaneous Renal Intervention  Christopher J.
Acupuncture Mayo Clinic Proceedings
Vulvovaginal Atrophy Mayo Clinic Proceedings
J.P. Donnelly, B.E. De Pauw  Clinical Microbiology and Infection 
Pancreatic Ductal Adenocarcinoma
Middle East Respiratory Syndrome: What Clinicians Need to Know
Highlights From the Third Annual Mayo Clinic Conference on Systems Engineering and Operations Research in Health Care  Janine R.A. Kamath, MBA, MA, John.
Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline  J. Taylor Hays, MD, Jon O. Ebbert,
Refurbishing Mayo Clinic Proceedings:
Antidepressants and Brain Neurochemistry
Gastric Signet Ring Cell Carcinoma
Pharmacogenomics: Precision Medicine and Drug Response
Comparison of antifungal MICs for yeasts obtained using the EU-CAST method in a reference laboratory and the Etest in nine different hospital laboratories 
Primary Signet Ring Cell Carcinoma of the Prostate
Management of Adult Onset Seizures
Complex Regional Pain Syndrome
Renal Pyelocalyceal Squamous Cell Carcinoma
Allen D. Seftel, MD, Martin Kathrins, MD, Craig Niederberger, MD 
Hepatocellular Carcinoma
68-Year-Old Man With Chronic Diarrhea, Nausea, and Vomiting
Methylphenidate: Its Pharmacology and Uses
Down River by Charles Munch
Lecturer name: Dr. Ahmed M. Albarrag
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species†   C.B. Moore,
Medical Treatment of Overactive Bladder: In Response
Mark A. Marinella, MD, Kenneth Greene, MD  Mayo Clinic Proceedings 
Mantle Cell Involvement of the Spleen
Squamous Cell Carcinoma of the Tongue
Preoperative Smoking Cessation: The Role of the Primary Care Provider
Medical Student Distress: Causes, Consequences, and Proposed Solutions
Constrictive Pericarditis Due to Graft-vs-Host Disease
Guru Sonpavde, MD, Teresa G. Hayes, MD  Mayo Clinic Proceedings 
Aptamer released caused by various drug classes.
Clomiphene-Induced Severe Hypertriglyceridemia and Pancreatitis
Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical.
The Obesity Paradox: Perception vs Knowledge
Prolonged QT Syndrome: Perioperative Management
Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”
Presentation transcript:

Current Concepts in Antifungal Pharmacology Russell E. Lewis, PharmD  Mayo Clinic Proceedings  Volume 86, Issue 8, Pages 805-817 (August 2011) DOI: 10.4065/mcp.2011.0247 Copyright © 2011 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 1 Timeline of systemic antifungal drugs. Mayo Clinic Proceedings 2011 86, 805-817DOI: (10.4065/mcp.2011.0247) Copyright © 2011 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 2 Sites of action and mechanisms of systemic antifungal agents. FKS1, FKS2 catalytic subunits of the glucan synthase complex are the putative target binding site of echinocandins. Rho is a cell wall-regulating protein. *Isavuconazole is still in phase 3 trials. Mayo Clinic Proceedings 2011 86, 805-817DOI: (10.4065/mcp.2011.0247) Copyright © 2011 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 3 Spectrum of action of systemic antifungal agents. Solid blocks represent species in which the antifungal agent has demonstrated microbiological and clinical efficacy. Blocks with dotted lines indicate fungal genera/species in which resistance is common. AMB = amphotericin; ANID = anidulafungin; CAS = caspofungin; 5-FC = flucytosine; FLU = fluconazole; ITRA = itraconazole; MICA = micafungin; POSA = posaconazole; VORI = voriconazole. Mayo Clinic Proceedings 2011 86, 805-817DOI: (10.4065/mcp.2011.0247) Copyright © 2011 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 4 Common toxicities of antifungal agents. CNS = central nervous system; 5-FC = flucytosine; GI = gastrointestinal; IV = intravenous; QTc = corrected QT interval. Mayo Clinic Proceedings 2011 86, 805-817DOI: (10.4065/mcp.2011.0247) Copyright © 2011 Mayo Foundation for Medical Education and Research Terms and Conditions